September 5, 2017
Ottawa, September 21, 2017 With regards to the provisional application of the Comprehensive and Economic Trade Agreement (CETA), Pamela Fralick, President, Innovative Medicines Canada issued the following statement: “Innovative Medicines […]
Ottawa, September 11, 2017 The following statement can be attributed to Innovative Medicines Canada’s president, Pamela Fralick: “Innovative Medicines Canada is supportive of the actions the federal government is taking […]
Ottawa, September 7, 2017 The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “Innovative Medicines Canada (IMC) has supported the Comprehensive and Economic Trade Agreement (CETA) […]
Innovative Medicines Canada has been designated a Canadian Compassionate Company by the Canadian Hospice Palliative Care Association […]
Ottawa, August 4, 2017 The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “Innovative Medicines Canada and its member companies support policies and practices that place […]
